# Phase II Study of THDBH120 Injection in Overweight or Obese Subjects

> **NCT07036601** · PHASE2 · RECRUITING · sponsor: **Tonghua Dongbao Pharmaceutical Co.,Ltd** · enrollment: 276 (estimated)

## Conditions studied

- Overweight or Obese

## Interventions

- **DRUG:** THDBH120 injection
- **DRUG:** Placebo of THDBH120 injection

## Key facts

- **NCT ID:** NCT07036601
- **Lead sponsor:** Tonghua Dongbao Pharmaceutical Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-06
- **Primary completion:** 2026-02-13
- **Final completion:** 2026-03-11
- **Target enrollment:** 276 (ESTIMATED)
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07036601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07036601, "Phase II Study of THDBH120 Injection in Overweight or Obese Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07036601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*